Measuring the quality of therapeutic apheresis care in the pediatric intensive care unit

Jeffrey B. Sussmane, Dan Torbati, Howard Gitlow

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Our goal was to measure the quality of care provided in the Pediatric Intensive Care Unit (PICU) during Therapeutic Apheresis (TA). We described the care as a step by step process. We designed a flow chart to carefully document each step of the process. We then defined each step with a unique clinical indictor (CI) that represented the exact task we felt provided quality care. These CIs were studied and modified for 1 year. We measured our performance in this process by the number of times we accomplished the CI vs. the total number of CIs that were to be performed. The degree of compliance, with these clinical indicators, was analyzed and used as a metric for quality by calculating how close the process is running exactly as planned or "in control." The Apheresis Process was in control (compliance) for 47% of the indicators, as measured in the aggregate for the first observational year. We then applied the theory of Total Quality Management (TQM) through our Design, Measure, Analyze, Improve, and Control (DMAIC) model. We were able to improve the process and bring it into control by increasing the compliance to > 99.74%, in the aggregate, for the third and fourth quarter of the second year. We have implemented TQM to increase compliance, thus control, of a highly complex and multidisciplinary Pediatric Intensive Care therapy. We have shown a reproducible and scalable measure of quality for a complex clinical process in the PICU, without additional capital expenditure. J. Clin. Apheresis, 2012.

Original languageEnglish (US)
Pages (from-to)43-50
Number of pages8
JournalJournal of Clinical Apheresis
Volume27
Issue number2
DOIs
StatePublished - Jan 1 2012

Fingerprint

Pediatric Intensive Care Units
Blood Component Removal
Compliance
Total Quality Management
Quality of Health Care
Capital Expenditures
Therapeutics
Critical Care
Pediatrics

Keywords

  • apheresis
  • children's hospital
  • clinical indicators
  • pediatric intensive care unit
  • performance improvement
  • quality, total quality management

ASJC Scopus subject areas

  • Hematology

Cite this

Measuring the quality of therapeutic apheresis care in the pediatric intensive care unit. / Sussmane, Jeffrey B.; Torbati, Dan; Gitlow, Howard.

In: Journal of Clinical Apheresis, Vol. 27, No. 2, 01.01.2012, p. 43-50.

Research output: Contribution to journalArticle

@article{1a948be7ac8f491d8ea01d9b55863501,
title = "Measuring the quality of therapeutic apheresis care in the pediatric intensive care unit",
abstract = "Our goal was to measure the quality of care provided in the Pediatric Intensive Care Unit (PICU) during Therapeutic Apheresis (TA). We described the care as a step by step process. We designed a flow chart to carefully document each step of the process. We then defined each step with a unique clinical indictor (CI) that represented the exact task we felt provided quality care. These CIs were studied and modified for 1 year. We measured our performance in this process by the number of times we accomplished the CI vs. the total number of CIs that were to be performed. The degree of compliance, with these clinical indicators, was analyzed and used as a metric for quality by calculating how close the process is running exactly as planned or {"}in control.{"} The Apheresis Process was in control (compliance) for 47{\%} of the indicators, as measured in the aggregate for the first observational year. We then applied the theory of Total Quality Management (TQM) through our Design, Measure, Analyze, Improve, and Control (DMAIC) model. We were able to improve the process and bring it into control by increasing the compliance to > 99.74{\%}, in the aggregate, for the third and fourth quarter of the second year. We have implemented TQM to increase compliance, thus control, of a highly complex and multidisciplinary Pediatric Intensive Care therapy. We have shown a reproducible and scalable measure of quality for a complex clinical process in the PICU, without additional capital expenditure. J. Clin. Apheresis, 2012.",
keywords = "apheresis, children's hospital, clinical indicators, pediatric intensive care unit, performance improvement, quality, total quality management",
author = "Sussmane, {Jeffrey B.} and Dan Torbati and Howard Gitlow",
year = "2012",
month = "1",
day = "1",
doi = "10.1002/jca.20318",
language = "English (US)",
volume = "27",
pages = "43--50",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Measuring the quality of therapeutic apheresis care in the pediatric intensive care unit

AU - Sussmane, Jeffrey B.

AU - Torbati, Dan

AU - Gitlow, Howard

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Our goal was to measure the quality of care provided in the Pediatric Intensive Care Unit (PICU) during Therapeutic Apheresis (TA). We described the care as a step by step process. We designed a flow chart to carefully document each step of the process. We then defined each step with a unique clinical indictor (CI) that represented the exact task we felt provided quality care. These CIs were studied and modified for 1 year. We measured our performance in this process by the number of times we accomplished the CI vs. the total number of CIs that were to be performed. The degree of compliance, with these clinical indicators, was analyzed and used as a metric for quality by calculating how close the process is running exactly as planned or "in control." The Apheresis Process was in control (compliance) for 47% of the indicators, as measured in the aggregate for the first observational year. We then applied the theory of Total Quality Management (TQM) through our Design, Measure, Analyze, Improve, and Control (DMAIC) model. We were able to improve the process and bring it into control by increasing the compliance to > 99.74%, in the aggregate, for the third and fourth quarter of the second year. We have implemented TQM to increase compliance, thus control, of a highly complex and multidisciplinary Pediatric Intensive Care therapy. We have shown a reproducible and scalable measure of quality for a complex clinical process in the PICU, without additional capital expenditure. J. Clin. Apheresis, 2012.

AB - Our goal was to measure the quality of care provided in the Pediatric Intensive Care Unit (PICU) during Therapeutic Apheresis (TA). We described the care as a step by step process. We designed a flow chart to carefully document each step of the process. We then defined each step with a unique clinical indictor (CI) that represented the exact task we felt provided quality care. These CIs were studied and modified for 1 year. We measured our performance in this process by the number of times we accomplished the CI vs. the total number of CIs that were to be performed. The degree of compliance, with these clinical indicators, was analyzed and used as a metric for quality by calculating how close the process is running exactly as planned or "in control." The Apheresis Process was in control (compliance) for 47% of the indicators, as measured in the aggregate for the first observational year. We then applied the theory of Total Quality Management (TQM) through our Design, Measure, Analyze, Improve, and Control (DMAIC) model. We were able to improve the process and bring it into control by increasing the compliance to > 99.74%, in the aggregate, for the third and fourth quarter of the second year. We have implemented TQM to increase compliance, thus control, of a highly complex and multidisciplinary Pediatric Intensive Care therapy. We have shown a reproducible and scalable measure of quality for a complex clinical process in the PICU, without additional capital expenditure. J. Clin. Apheresis, 2012.

KW - apheresis

KW - children's hospital

KW - clinical indicators

KW - pediatric intensive care unit

KW - performance improvement

KW - quality, total quality management

UR - http://www.scopus.com/inward/record.url?scp=84859701487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859701487&partnerID=8YFLogxK

U2 - 10.1002/jca.20318

DO - 10.1002/jca.20318

M3 - Article

C2 - 22095668

AN - SCOPUS:84859701487

VL - 27

SP - 43

EP - 50

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 2

ER -